Fidelity Investments’s Cantel Medical Corporation CMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-24
Closed -$2K 5196
2021
Q1
$2K Hold
24
﹤0.01% 3783
2020
Q4
$2K Hold
24
﹤0.01% 3642
2020
Q3
$1K Sell
24
-270
-92% -$13.3K ﹤0.01% 3628
2020
Q2
$13K Sell
294
-201
-41% -$7.5K ﹤0.01% 3080
2020
Q1
$18K Buy
495
+107
+28% +$6.08K ﹤0.01% 2977
2019
Q4
$28K Buy
388
+29
+8% +$2.1K ﹤0.01% 3031
2019
Q3
$27K Hold
359
﹤0.01% 3005
2019
Q2
$29K Sell
359
-294
-45% -$20.7K ﹤0.01% 2993
2019
Q1
$44K Buy
653
+5
+0.8% +$379 ﹤0.01% 2812
2018
Q4
$48K Sell
648
-105,644
-99% -$8.72M ﹤0.01% 2736
2018
Q3
$9.79M Sell
106,292
-181,408
-63% -$17.3M ﹤0.01% 1943
2018
Q2
$28.3M Sell
287,700
-820,977
-74% -$91.8M ﹤0.01% 1545
2018
Q1
$124M Buy
1,108,677
+187,309
+20% +$21M 0.01% 890
2017
Q4
$94.8M Sell
921,368
-135,165
-13% -$13.5M 0.01% 1020
2017
Q3
$99.5M Buy
1,056,533
+368,381
+54% +$29.1M 0.01% 977
2017
Q2
$53.6M Buy
688,152
+113,942
+20% +$8.56M 0.01% 1267
2017
Q1
$46M Buy
574,210
+450,187
+363% +$35.8M 0.01% 1338
2016
Q4
$9.77M Buy
124,023
+164
+0.1% +$12.7K ﹤0.01% 1982
2016
Q3
$9.66M Buy
123,859
+212
+0.2% +$15.4K ﹤0.01% 1994
2016
Q2
$8.5M Sell
123,647
-2
-0% -$138 ﹤0.01% 2036
2016
Q1
$8.82M Buy
+123,649
New +$7.76M ﹤0.01% 2009
2013
Q4
Sell
-60,864
Closed -$1.94M 2717
2013
Q3
$1.94M Buy
+60,864
New +$1.62M ﹤0.01% 2355

Fidelity Investments's CMD Position: Q2 2021 in Review

Fidelity Investments sold out of Cantel Medical Corporation (CMD) in Q2 2021, closing a stake of 24 shares — an estimated $2K sold.

Fidelity Investments first reported a position in CMD in Q3 2013 and held it in 22 quarters. The position peaked at $124M in Q1 2018. 0 funds tracked by Wall St. Rank hold CMD as of Q2 2021.

  • Fidelity Investments reported no remaining Cantel Medical Corporation position as of Q2 2021 after selling out during the quarter.
  • Fidelity Investments sold 24 Cantel Medical Corporation shares in Q2 2021, an estimated $2K.
  • Fidelity Investments first reported a position in Cantel Medical Corporation in Q3 2013 and held it in 22 quarters.
  • Fidelity Investments's Cantel Medical Corporation position peaked at $124M in Q1 2018.
  • 0 funds tracked by Wall St. Rank held Cantel Medical Corporation as of Q2 2021.

Based on Fidelity Investments's 13F filing for Q2 2021, filed 13 Aug 2021.